Effectiveness of Qualia NAD+ Supplementation on Intracellular NAD Levels
Not Applicable
Recruiting
- Conditions
- NAD+ Levels in the Blood
- Interventions
- Dietary Supplement: Qualia NAD+Other: Placebo
- Registration Number
- NCT06505967
- Lead Sponsor
- Qualia Life Sciences
- Brief Summary
The goal of this clinical trial is to determine if Qualia NAD+ effectively increases NAD+ levels in the blood and to evaluate its safety.
Researchers will compare Qualia NAD+ to a placebo (a look-alike substance that contains no active drug) to assess its efficacy in increasing NAD+ levels in the blood.
Participants will:
Take Qualia NAD+ or a placebo every day for 4 weeks. Undergo blood tests before and after the trial.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 200
Inclusion Criteria
Not provided
Exclusion Criteria
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Qualia NAD+ Qualia NAD+ - Placebo Placebo -
- Primary Outcome Measures
Name Time Method NAD+ Levels in the Blood 4 weeks
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Qualia Life Sciences
🇺🇸Carlsbad, California, United States